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Abstract In serum-starved NIH 3T3 fibroblast cultures, zinc
(15^40 WM) enhanced both the individual and combined
stimulatory effects of insulin and ethanol (EtOH) on DNA
synthesis. Zinc, but not EtOH, also promoted the stimulatory
effects of insulin on activating phosphorylation of p42/p44
mitogen-activated protein (MAP) kinases. In the presence of
zinc, insulin induced premature expression of cyclin E during
early G1 phase; EtOH partially restored the normal timing (late
G1 phase) of cyclin E expression. The results suggest that zinc
and EtOH promote insulin-induced DNA synthesis by different
mechanisms; while zinc acts by enhancing the effects of insulin
on MAP kinase activation, EtOH may act by ensuring timely
zinc-dependent insulin-induced expression of cyclin E.
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1. Introduction
Although zinc is an important micronutrient which, in ad-
dition to other biological e¡ects, is required for normal
growth [1^3], relatively little is known about the possible in-
teractions between zinc and growth factors in regulating mito-
genesis. Earlier we found that in various cell lines, including
NIH 3T3 ¢broblasts, zinc was able to enhance insulin-induced
DNA synthesis if ethanol (EtOH) was also present [4,5]. This
suggested that the insulin-dependent growth regulatory mech-
anism may be a target for the actions of zinc.
Heavy alcohol consumption promotes development of cer-
tain cancers induced by carcinogens [6^10]. As suggested by
others [11], these alcohol e¡ects may be mediated, at least in
part, by increased mitogenesis such as occurring in the simul-
taneous presence of EtOH, insulin and zinc [4,5]. Accordingly,
the actual zinc status may in£uence the e¡ect of EtOH, and
possibly some growth factors, on carcinogenesis. In view of
these possibilities, it is of interest to determine the signal
transduction mechanism(s) mediating the e¡ects of zinc, insu-
lin and EtOH on mitogenesis. In this regard, in an earlier
work we found that EtOH can enhance the stimulatory e¡ect
of insulin on p70 S6 kinase activity [5]. However, the promot-
ing e¡ect of EtOH was relatively small suggesting that there
may be another mechanism involved in the mediation of
EtOH e¡ects on DNA synthesis.
Considering that activation of p42/p44 mitogen-activated
protein (MAP) kinases is thought to be required for ¢broblast
growth [12], and that timely expression of cyclins, the activat-
ing partners of cyclin-dependent kinases (Cdk), are important
for cell cycle progression [13], in this work we concentrated
our e¡orts to determine the e¡ects of zinc, insulin and EtOH
on MAP kinase activation and cyclin expression. The results
obtained suggest that zinc and EtOH are capable of enhanc-
ing the mitogenic e¡ect of insulin by di¡erent mechanisms.
Thus, while zinc most probably acts by promoting the e¡ect
of insulin on MAP kinase activation, EtOH is likely to act by
shifting zinc-plus-insulin-induced expression of cyclin E from
an early to a later phase of the G1 cell cycle period.
2. Materials and methods
2.1. Materials
Spectroscopic grade EtOH was purchased from Aldrich and was
redistilled prior to use to remove possible traces of benzene (in [4], this
EtOH preparation is referred to as preparation ‘5’); the ¢rstV35% of
the distillate was discarded. PD 98059 was bought from Calbiochem;
zinc chloride was from Sigma; insulin was purchased from Boehringer
Mannheim; the p42/p44 MAPK Western blot kit, including activating
phosphorylation site (tyrosine-204)-speci¢c antibody, was bought
from New England Biolabs; rabbit polyclonal antibodies against cy-
clins A, D1, and E, as well as peroxidase-conjugated goat anti-rabbit
IgG and protein A-agarose were bought from Santa Cruz Biotechnol-
ogy; [methyl-3H]thymidine (500 mCi/mmol) was purchased from Du-
pont NEN; and tissue culture reagents, including fetal calf serum,
were from GIBCO-BRL.
2.2. Cell culture
NIH 3T3 clone-7 ¢broblasts (American Type Culture Collection)
were cultured in 10% fetal calf serum-containing Dulbecco’s modi¢ed
Eagle’s medium as in [4].
2.3. Determination of DNA synthesis
Fibroblasts were grown in 12-well tissue culture plates to about
40% con£uency in the presence of 10% serum, washed, incubated in
serum-free medium for 24 h, and then washed again 3 h prior to
treatments. The cells (70^80% con£uent) were ¢rst treated (in se-
rum-free medium; incubation volume, 0.75 ml) with 40 WM zinc
chloride (dissolved in medium) for 10 min or 3 h, as indicated, and
then with EtOH and insulin for 18 h. [Methyl-3H]thymidine (1 WCi/
well) was added for the last 60 min of treatment. In preliminary
experiments we determined that in each case maximal incorporation
of thymidine into DNA occurs between 17^18 h of treatment, and
that none of these agents, alone or in combination, increases cellular
uptake of thymidine during the ¢rst 15 h of treatment. At the con-
clusion of treatments, the cells were washed twice with phosphate-
bu¡ered saline, then four times with 5% trichloroacetic acid, and
¢nally twice with absolute ethanol. The acid-insoluble material was
redissolved in 0.3 M sodium hydroxide, and an aliquot was taken to
measure DNA-associated 3H activity in a liquid scintillation counter.
The cell numbers in V80% con£uent cultures were in the range of
1.5^1.7U105/well.
2.4. Western blot analysis of phosphorylation of p42/p44 MAP kinases
Serum-starved (24 h) NIH 3T3 cells, grown in 35 mm diameter
dishes to 70^80% con£uency, were ¢rst incubated with 40 WM zinc
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for 2 min, and then treated with 60 mM EtOH and/or insulin for 10
min, 1 h or 6 h. Samples for immunoblot analysis were prepared as
indicated earlier [14,15]. Phosphospeci¢c MAP kinase antibody was
used to detect the phosphorylated (activated) forms of p42/p44 MAP
kinases. The Western immunoblotting protocol was performed ac-
cording to the instructions provided by the manufacturer. The relative
changes in the intensity of protein phosphorylation was determined by
Storm 840 phosphoimager (Molecular Dynamics).
2.5. Western blot analysis of cyclins
Serum-starved NIH 3T3 ¢broblasts were treated for 6 or 12 h with
zinc, insulin and/or EtOH as described in Fig. 4, then samples were
prepared and subjected to Western blot analysis of cyclins as in [16],
and the changes in cyclin expression were quanti¢ed as above.
3. Results
3.1. Zinc enhances insulin- and EtOH-stimulated
DNA synthesis
In the absence of zinc, treatment of serum-starved NIH 3T3
¢broblasts with insulin resulted in only a slight increase in
DNA synthesis, while 60 mM EtOH alone was without e¡ects
(Fig. 1A). Pretreatment of ¢broblasts with 40 WM zinc for 3 h
(Fig. 1A) or 10 min (Fig. 1B) prior to EtOH/insulin treat-
ments similarly enhanced both the individual and combined
e¡ects of insulin and EtOH. The concentration of EtOH (60
mM) used was nearly optimal while that of insulin (500 nM)
was optimal for these e¡ects [4,5]. The combined treatments
with these three agents increased DNA content about 1.7-fold
as determined by ethidium bromide (not shown), indicating
that increased [3H]thymidine incorporation into DNA (Fig. 1)
was indeed due to increased DNA synthesis. This conclusion
is further supported by additional ¢ndings that zinc, insulin
and EtOH had detectable e¡ects on [3H]thymidine incorpora-
tion into DNA only after an about 16 h incubation period, i.e.
when cells would be expected to enter the DNA synthesizing
S cell cycle period.
Lower (15^25 WM) concentrations of zinc signi¢cantly pro-
moted DNA synthesis only if insulin and EtOH were simulta-
neously present. Again, the potentiating e¡ects of lower con-
centrations of zinc were about the same when zinc was added
3 h (Fig. 1A) or only 10 min (Fig. 1B) prior to EtOH and
insulin. Since cellular uptake of zinc is known to be a slow
process, these data strongly suggest that the observed e¡ects
of zinc on DNA synthesis may not require its incorporation
into cells.
The MEK1 inhibitor PD 98059 [17], used at 25^50 WM
concentrations (which have been commonly used in cell cul-
tures to achieve optimal e¡ects), inhibited both the single and
combined e¡ects of zinc, insulin and EtOH on DNA synthesis
(Fig. 2). This suggested that MAP kinase activation was im-
Fig. 1. Combined e¡ects of zinc, insulin and EtOH on DNA synthe-
sis in NIH 3T3 ¢broblasts. Serum-starved (24 h) NIH 3T3 ¢bro-
blasts were incubated ¢rst with 0^40 WM zinc for 3 h (A) or 10 min
(B), as indicated, followed by incubations for 18 h in the absence
(b) or presence of 500 nM insulin (R), 60 mM EtOH (F) or insulin
plus EtOH (8) ; [3H]thymidine was added for the last 60 min of
the treatment. Each point represents the mean þ S.D. of six incuba-
tions in a representative experiment. Similar results were obtained in
two other experiments each performed in triplicate.
Fig. 2. Inhibitory e¡ects of PD 98059 on DNA synthesis induced
by zinc, insulin and EtOH in NIH 3T3 ¢broblasts. Serum-starved
NIH 3T3 cells were ¢rst treated with 40 WM zinc for 3 h, followed
by incubations for 18 h in the absence or presence of 500 nM insu-
lin and/or 60 mM EtOH as indicated; PD 98059 was either absent
(E) or present at 25 WM (l) or 50 WM (F) concentrations. The
data are the means þ S.D. of six incubations in a single experiment.
Similar inhibitory e¡ects were obtained in two other experiments
each performed in triplicate. *Signi¢cantly (P6 0.01) di¡erent from
the corresponding value in the absence of inhibitor (Student’s
t-test).
Fig. 3. Western blot analysis of the e¡ects of zinc, insulin and
EtOH on the phosphorylation of p42/p44 MAP kinases. Serum-
starved NIH 3T3 cells were ¢rst treated with 40 WM zinc for 2 min,
followed by incubations for 10 min, 1 h, or 6 h in the absence or
presence of 500 nM insulin and/or 60 mM EtOH as indicated. This
experiment was repeated once with similar results.
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portant in each case, although not each agent necessarily ac-
tivated MAP kinases. To clarify the contribution of MAP
kinases to the mitogenic e¡ects of zinc, insulin and EtOH,
we next determined the ability of these agents to induce acti-
vating phosphorylations of p42/p44 MAP kinases.
3.2. E¡ects of zinc, insulin and EtOH on activating
phosphorylations of MAP kinases
In the absence of zinc, insulin had only small stimulatory
e¡ects on MAP kinase phosphorylation at the tyrosine site
which is known to result in enzyme activation [18] (Fig. 3).
Zinc (40 WM) alone enhanced phosphorylation of MAP kin-
ases and, in addition, it clearly promoted the stimulatory ef-
fects of insulin particularly after 10 and 60 min treatments
(Fig. 3). In contrast, EtOH (60 mM) alone or in combination
with zinc and/or insulin had no e¡ects on MAP kinase phos-
phorylation (Fig. 3).
3.3. E¡ects of zinc, insulin and EtOH on the expression of
cyclins
Both in the absence of zinc (not shown) and in its presence
(Fig. 4), insulin similarly enhanced expression of cyclin A
after 12 h, but not 6 h, treatment. It should be added that
maximum insulin-induced expression of cyclin A occurred
after about 16 h of starting the treatment with insulin (not
shown), indicating a normal expression pattern for this cyclin
[19]. EtOH alone (not shown) or in the presence of insulin and
zinc had no e¡ects on cyclin A expression (Fig. 4).
In the presence of zinc, expression of cyclin D1 was en-
hanced by insulin during the ¢rst 6 h of treatment (i.e. during
early G1 phase), as expected [19], followed by decreased ex-
pression between 6^12 h of treatment. Insulin had very similar
e¡ects on cyclin D1 expression in the absence of zinc (not
shown). Again, zinc and EtOH did not alter cyclin D1 expres-
sion (Fig. 4).
Unexpectedly, in the presence of zinc, but not in its ab-
sence, insulin induced strong expression of cyclin E during
the ¢rst 6 h of treatment (Fig. 4). Co-treatment with EtOH
clearly shifted zinc-plus-insulin-induced expression of cyclin E
from the 0^6 h treatment period to the 6^12 h period (Fig. 4).
Accordingly, in the presence of EtOH, zinc plus insulin in-
duced the synthesis of about 2.1-fold more cyclin E during the
6^12 h treatment period compared to the ¢rst 6 h, while the
same treatments performed in the absence of EtOH produced
about 1.9-fold more cyclin E during the ¢rst 6 h (Fig. 4).
4. Discussion
In NIH 3T3 ¢broblasts, insulin alone has proved to be a
weak inducer of both DNA synthesis and MAP kinase acti-
vation. However, we have found that in these cells zinc can
enhance the stimulatory e¡ects of insulin on both the phos-
phorylation/activation of p42/p44 MAP kinases and DNA
synthesis. Since activation of MAP kinases is important for
¢broblast proliferation [12], it is reasonable to suggest that
there is a causal relationship between the above potentiating
e¡ects of zinc.
Zinc had similar potentiating e¡ects when used 3 h or
10 min prior to other treatments. Since cellular uptake of
zinc is slow, these data suggest that zinc may exert its e¡ects
without entering the cells. In this context, it was recently
suggested that in hepatocytes, mobilization of intracellular
calcium by added zinc is mediated by a putative cell mem-
brane ion receptor protein [20]. The possible role of a metal
ion receptor in the mediation of zinc e¡ects on DNA synthesis
and MAP kinase activation is presently under study in this
laboratory.
Interestingly, although EtOH had no e¡ects on zinc-plus-
insulin-induced MAP kinase activation, it still was able to
greatly enhance the combined stimulatory e¡ects of zinc and
insulin on DNA synthesis. Detailed examination of expression
of cyclins revealed that insulin can greatly enhance cyclin E
expression only in the presence of zinc. However, while we
previously observed ¢broblast growth factor-induced cyclin E
expression during late G1 phase [16], when it should normally
appear (see, for example, ref. [13]), in the presence of zinc and
insulin cyclin E appeared during the ¢rst 6 h of treatment, i.e.
during the early G1 period. EtOH clearly shifted the bulk of
cyclin E expression from an earlier to a later phase of the G1
cell cycle period. In contrast to cyclin E expression, the stim-
ulatory e¡ects of insulin on the expression of cyclins D1 and
A were not a¡ected by zinc and EtOH, and these cyclins
appeared in a timely fashion as described for other stimulators
of the cell cycle [13].
It appears that execution of a productive cell cycle requires
that expression of various cyclins remains on schedule. This is
because the various cyclins, together with the corresponding
Cdks, have speci¢c biological functions at a given time of the
cell cycle. For example, Cdk4-cyclin D complexes induce the
release of E2F transcription factor from the retinoblastoma
(pRb)-E2F inhibitory complex by phosphorylating speci¢c
sites on pRb. Released E2F then induces transcription of cy-
Fig. 4. Western blot analysis of the e¡ects of zinc, insulin and
EtOH on the expression of cyclins. Serum-starved NIH 3T3 cells
were ¢rst treated with 40 WM zinc for 2 min, unless indicated other-
wise, followed by incubations for 6 or 12 h in the absence or pres-
ence of 500 nM insulin and/or 60 mM EtOH, as indicated. This ex-
periment was repeated twice with similar results.
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clin E, among other proteins, leading to further phosphoryla-
tion of pRb by the Cdk2-cyclin E complex as well as to a
large increase in E2F-dependent transcription and the onset of
S phase [13]. Accordingly, it is likely that the induction of
early expression of cyclin E by zinc and insulin disturbs the
normal sequence of cell cycle to an extent that their large
e¡ects on MAP kinase activation cannot translate to a sim-
ilarly large e¡ect on DNA synthesis. Based on these consid-
erations, it is conceivable that the ability of EtOH to shift the
bulk of zinc-plus-insulin-induced cyclin E expression from an
earlier to a later G1 phase signi¢cantly contributes to its zinc-
dependent potentiating e¡ects on insulin-induced DNA syn-
thesis.
In summary, we have found that while zinc can enhance
insulin-induced DNA synthesis by a MAP kinase-dependent
mechanism, zinc and insulin also induce abnormal expression
of cyclin E which appears to limit the extent of DNA syn-
thesis. In the presence of EtOH, zinc-plus-insulin-induced ex-
pression of cyclin E becomes more normal, probably account-
ing for the zinc-dependent potentiating e¡ect of EtOH on
insulin-induced DNA synthesis. Based on these observations,
it appears worthwhile to further examine the possible relation-
ship between the zinc- and insulin-dependent e¡ects of EtOH
on DNA synthesis and carcinogenesis.
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